Matheson Recalls Medical Air Cylinders Due to Carbon Dioxide Impurity
Matheson, Inc. is recalling Medical Air cylinders in Michigan and Wisconsin because they failed impurity specifications for carbon dioxide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class III, which is defined as unlikely to cause adverse health consequences. The hazard is a specification failure (carbon dioxide impurity) with no reported illnesses, fitting the criteria for a moderate or low-risk precautionary recall.
Plain-English summary
Matheson, Inc. is recalling 137,880 cubic feet of Medical Air, USP, in various cylinder sizes (E, 22, 40, 200, 220, and 300 cubic feet). The product is a prescription-only respiratory drug distributed in Michigan and Wisconsin.
The recall was initiated because the product failed impurities and degradation specifications, specifically showing out-of-specification results for carbon dioxide. The source text does not report any illnesses or injuries associated with this recall.
Consumers and healthcare providers should stop using the affected lots and contact Matheson, Inc. for further instructions or a replacement. The specific lot numbers affected are listed in the official recall documentation.
The recalled product
- Product
- AIR (AIR)
- Brand
- AIR
- Manufacturer
- Matheson, Inc.
- Category
- Drug — Respiratory Gas
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- A) Lot #: BAHC564281A
- BAHC564281B
- BAHC546288A
- BAHC564288B
- BAHC546288C
- BAHC546288D
- BAHC546288E
- BAHC564307A
- BAHC564314A
- BAHC564329A. BAHC564329B
- BAHC564329C
- BAHC564329D
- BAHC564329E
- BAHC564344A
- BAHC565005A
- BAHC565006A
- BAHC565013A
- BAHC565015A
- BAHC565015B
- BAHC565015C
Distribution
Related recalls
Same hazard · impurity
See all →- ModerateHikma Recalls Ramipril Capsules Due to Process Impurity
FDA (Drugs) · 2026-09-02
- ModerateMedline Remedy Specialized Silicone Cream Recalled for Elevated Formaldehyde Levels
FDA (Drugs) · 2026-07-15
- SevereCinacalcet Hydrochloride Tablets Recalled for Elevated Impurity Levels
FDA (Drugs) · 2026-07-08
- HighDuloxetine 30mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17
- HighDuloxetine 60mg delayed-release capsules exceed nitrosamine impurity interim limit
FDA (Drugs) · 2026-06-17